Cell and gene therapies have the potential to transform the lives of patients with long-term or life-threatening illnesses. While there is great promise, bringing these new therapies to market is far from simple. One of the biggest challenges is the required long-term follow-up (LTFU) – the need to monitor patient outcomes and safety for up to 15 years.
Join IQVIA for this upcoming webinar on approaches to LTFU as required by regulators for CAGT clinical trials. Learn about challenges in conducting long-term follow-up studies, flexible virtual and hybrid approaches to LTFU studies that can reduce risk and improve the patient experience, and options to leverage and supplement existing registries data for long-term evidence generation.
For questions, contact This email address is being protected from spambots. You need JavaScript enabled to view it..
Presenters
Monica Shah, MD, FACC, Vice President and Head
Cell and Gene Therapy Center of Excellence, IQVIA
Erin Finot, MS, MBA, Global Head of Immuno-oncology
IQVIA Biotech
Elizabeth Powers, MBA, Vice President
IQVIA Divisions of Real World Solutions
Christopher Varner, Project Manager, Virtual Trial Solutions
IQVIA